Global Hospital Infection Therapeutics Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027

“Global Hospital Infection Therapeutics Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2027” is a recent report generated by MarketResearch.biz, which offers in-depth insights, revenue details, and other vital information regarding the global hospital infection therapeutics market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global hospital infection therapeutics market report has been segmented on the basis of therapeutics, infections, and region.

Introduction:

Nosocomial infections are also known as hospital-acquired/associated infections. Hospital-acquired infections are caused by viral, bacterial, and fungal pathogens. These infections can be acquired at hospital, nursing home, rehabilitation facility, outpatient clinic, or other clinical settings. Infections acquired in health care settings are among the major causes of death and increased morbidity among hospitalized patients. During hospitalization, patient is exposed to pathogens through different sources such as environment, healthcare staff, and other infected patients. According to WHO estimates in 2017, approximately 15% of all hospitalized patients suffer from these infections. Depending upon the type of infection and part of body infected, treatment of hospital acquired diseases differs.

Market Dynamics:

Key factors expected to drive growth of the global hospital infection therapeutics market is growing geriatric population. In addition, increasing number of operating room procedure, increasing healthcare expenditure, changing reimbursement policies are among some other factors expected to drive growth of the global hospital infection therapeutics market. Furthermore, increasing awareness regarding healthcare, availability advance medical facilities, government initiatives for healthcare management are some other factors expected to drive revenue growth of the target market over the forecast years. However, string regulatory rule may hamper the growth of the global hospital infection therapeutics market to a certain extend.

Trends:

Major players are focusing on carrying out various R&D activities, in order to prevent the growing incidences of hospital acquired infections. For instance, Merck & Co., Inc. is carrying our research and development activities for MK-3415A drug profile, in order to study infectious diseases. Government of various countries are formulating various policies and promoting the use of therapeutic for hospital acquired diseases. Government are taking initiatives to form patient safety networks and organizations focused on quality together are making an effort to improve infection control and reduce the number of patients who contract these conditions.

Regional Analysis:

The market in North America is expected to dominate the global hospital infection therapeutics market, owing to rising number of cases of chronic diseases with growing geriatric population in countries in the region. In addition, government of US and Canada are funding the R&D activities for preventing the various hospital acquired infections. For instance, in 2011, according to the centers for disease control and prevention, around 1.6 million hospital acquired infections have been reported from all types of bacteria in US every year. In contrast, the market in Asia Pacific is expected to be an emerging market for the global hospital infection therapeutics market, and is expected to register highest CAGR in during the forecasted period, owing to developing healthcare infrastructure and increasing healthcare expenditure in the region. Moreover, the markets in Europe, Latin America and Middle East & Africa are expected to register moderate growth rate over the forecast period.

GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SEGMENTATION:

Segmentation by therapeutics:

• Anti-bacterial Drugs
• Anti-fungal Drugs
• Anti-viral Drugs
• Others

Segmentation by infections:

• Hospital Acquired Pneumonia
• Urinary Tract Infections
• Gastrointestinal Disorders
• Bloodstream Infections
• Surgical Site Infections
• Other Hospital Infections (includes Pneumonia, Surgical Site Infections, etc.)

Segmentation by region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa